GPX8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63691282750733E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.96670021882051E-10 |
Normal-vs-Stage2 |
9.86060000000011E-05 |
Normal-vs-Stage3 |
5.88720000527232E-08 |
Normal-vs-Stage4 |
1.147680E-02 |
Stage1-vs-Stage2 |
2.010000E-01 |
Stage1-vs-Stage3 |
2.958900E-04 |
Stage1-vs-Stage4 |
1.955410E-01 |
Stage2-vs-Stage3 |
1.551970E-01 |
Stage2-vs-Stage4 |
4.232800E-01 |
Stage3-vs-Stage4 |
8.347800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.06421554796543E-14 |
Normal-vs-AfricanAmerican |
7.7334999959433E-08 |
Normal-vs-Asian |
3.860400E-02 |
Caucasian-vs-AfricanAmerican |
9.003200E-01 |
Caucasian-vs-Asian |
2.656600E-01 |
AfricanAmerican-vs-Asian |
3.476000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.97450952757572E-12 |
Normal-vs-Female |
1.42763578736549E-12 |
Male-vs-Female |
5.301400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.06689999998822E-06 |
Normal-vs-Extreme_Weight |
4.20063983597174E-12 |
Normal-vs-Obese |
8.28499491234425E-11 |
Normal-vs-Extreme_Obese |
2.487400E-01 |
Normal_Weight-vs-Extreme_Weight |
3.764400E-01 |
Normal_Weight-vs-Obese |
8.496000E-02 |
Normal_Weight-vs-Extreme_Obese |
2.685000E-01 |
Extreme_Weight-vs-Obese |
1.901850E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.722200E-02 |
Obese-vs-Extreme_Obese |
4.770200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.039460E-04 |
Normal-vs-Age(41-60Yrs) |
1.65012448150037E-12 |
Normal-vs-Age(61-80Yrs) |
2.0690005264612E-11 |
Normal-vs-Age(81-100Yrs) |
5.259900E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.713840E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.824110E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.132200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.099600E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.711000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.300800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.2179146580138E-13 |
Normal-VS-Type2 PRCC |
1.00970000138645E-08 |
Normal-VS-KIRP CIMP |
2.008500E-04 |
Normal-VS-Unclassified PRCC |
1.68669999967008E-07 |
Type1 PRCC-VS-Type2 PRCC |
4.754600E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.431900E-04 |
Type1 PRCC-VS-Unclassified PRCC |
6.335700E-02 |
Type2 PRCC-VS-KIRP CIMP |
5.402200E-04 |
Type2 PRCC-VS-Unclassified PRCC |
2.019700E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.378560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.81849999947303E-07 |
Normal-vs-N1 |
2.7531000001968E-07 |
Normal-vs-N2 |
3.260300E-02 |
N0-vs-N1 |
9.006000E-04 |
N0-vs-N2 |
1.658020E-03 |
N1-vs-N2 |
2.853600E-01 |
|
|